On a mixed day, two biopharma firms’ insulin drugs vie for investors
|
1
|
Mannkind
|
Jun 19, 2013 11:56AM
|
2 Biotech Approval Outcomes That Might Affect You
|
|
Mannkind
|
Jun 19, 2013 10:11AM
|
MannKind CFO says will consider partnering after examining data
|
1
|
Mannkind
|
Jun 18, 2013 03:44PM
|
Re: Now this is the MannKind...
|
|
Mannkind
|
Jun 18, 2013 11:18AM
|
Now this is the MannKind...
|
2
|
Mannkind
|
Jun 18, 2013 10:21AM
|
Why MannKind Is Poised to Pull Back
|
|
Mannkind
|
Jun 18, 2013 09:57AM
|
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes M
|
|
Mannkind
|
Jun 18, 2013 09:02AM
|
Most active Nasdaq-traded stocks
|
|
Mannkind
|
Jun 17, 2013 02:26PM
|
Re: David Kliff And Diabeticinvestor.com
|
1
|
Mannkind
|
Jun 17, 2013 02:23PM
|
MannKind Still Treading Water, So Why Are Investors Surfing?
|
|
Mannkind
|
Jun 14, 2013 03:15PM
|
MannKind Corporation (MNKD): Are Hedge Funds Right About This Stock?
|
1
|
Mannkind
|
Jun 14, 2013 03:04PM
|
Re: Activity Alert for MannKind (MNKD)
|
2
|
Mannkind
|
Jun 14, 2013 11:45AM
|
Re: Activity Alert for MannKind (MNKD)
|
|
Mannkind
|
Jun 13, 2013 06:12PM
|
Re: Pricing MannKind Corporation On A Stand-Alone Basis
|
2
|
Mannkind
|
Jun 13, 2013 05:33PM
|
Activity Alert for MannKind (MNKD)
|
|
Mannkind
|
Jun 13, 2013 05:10PM
|
For Love and Money: Three Growth Stocks from Casey’s Alex Daley
|
4
|
Mannkind
|
Jun 13, 2013 02:12PM
|
3 Reasons You Shouldn't Buy Stocks in Biotech
|
|
Mannkind
|
Jun 13, 2013 10:41AM
|
Re: Pricing MannKind Corporation On A Stand-Alone Basis
|
|
Mannkind
|
Jun 12, 2013 03:11PM
|
Buying High the New Winning Investment Strategy?
|
1
|
Mannkind
|
Jun 12, 2013 01:33PM
|
Re: MannKind to Present at Wells Fargo Securities Research & Economics 2013 Healthca
|
|
Mannkind
|
Jun 11, 2013 05:56PM
|